Log In
Sign Up It's Free!
English Edition

Univadis

X
Univadis from Medscape

No Results

News & Perspective Drugs & Diseases CME & Education Video Decision Point
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out

processing....

Diplopia (Double Vision)

Updated: Aug 05, 2024
  • Author: Jitander Dudee, MD, MA(Cantab), FACS, FRCOphth; Chief Editor: Andrew G Lee, MD
  • Share
  • Print
  • Feedback
Overview

Background

Diplopia is the subjective complaint of seeing two images instead of one and is often referred to as double-vision in lay parlance. [] The term diplopia is derived from two Greek words: diplous, meaning double, and ops, meaning eye. Diplopia often is the first manifestation of many systemic disorders, especially muscular or neurologic processes. [, ] An accurate, clear description of the symptoms (eg, constant or intermittent; variable or unchanging; at near or at far; with one eye [monocular] or with both eyes [binocular]; horizontal, vertical, or oblique) is critical to appropriate diagnosis and management. [, , ]

Binocular diplopia occurs only when both eyes are open and can be corrected by covering either eye. Monocular diplopia persists in one eye despite covering the other eye and usually can be corrected by using a pinhole. Monocular diplopia can be unilateral or bilateral. [] Physiologic diplopia is a normal phenomenon depending on the alignment of the ocular axes with the objects of regard (eg, focusing on a finger held close results in distant objects being blurry but double).

Further classification schemes for binocular diplopia include constant versus intermittent and vertical versus horizontal (or oblique) diplopia. Vertical diplopia indicates vertical alignment of the images, which usually suggests pathology in the vertical muscles, including superior oblique, inferior oblique, superior rectus, and inferior rectus. Horizontal diplopia suggests pathology of the medial or lateral rectus.

Animal models

Unless the visual fields of the eyes overlap, binocular diplopia cannot occur. Among vertebrates, the potential for diplopia (and for stereoscopic depth perception) depends on where the eyes are located in the head. Eyes located on either side of the head provide a wide visual field but with a less overlapped visual field. These animals have less field for binocular vision and less risk for diplopia when one eye becomes misaligned. However, when both eyes are located in the front of the head, a greater visual field overlap exists and, thus, a better binocular depth perception, as frequently seen in predators. Misalignment of such eyes may result in diplopia.

The eyes of birds demonstrate many unique anatomic features, one of which is the presence of multiple foveae and, in some cases, a streak fovea linking two foveae. Thus, they may be able to have two separate areas of regard without disabling diplopia. How the visual perception occurs in these cases remains debatable.

eMedicine Logo
Next:

Pathophysiology

Binocular diplopia (or true diplopia) is a breakdown in the fusional capacity of the binocular system. The normal neuromuscular coordination cannot maintain correspondence of the visual objects on the foveae of the two eyes. Rarely, fusion cannot occur because of dissimilar image size, which can occur after changes in the optical function of the eye after refractive surgery (eg, LASIK) or after a cataract is replaced by an intraocular lens or because of aniseikonia, which represents a discrepancy in image size perceived by the two eyes.

The distortion of one image may be interpreted as diplopia by the patient; however, the same object does not appear to be in two places but rather appears differently with each eye.

Monocular diplopia may result from abnormal light transmission to the retina (eg, corneal distortion or scarring, multiple openings in the iris, cataract or subluxation of the natural lens or pseudophakic lens implant, vitreous abnormalities, retinal conditions). Monocular diplopia must be distinguished from metamorphopsia, in which objects appear misshapen. []

eMedicine Logo
Previous
Next:

Epidemiology

Frequency

United States

From 2003 through 2012, there were 804,647 ambulatory and 49,790 emergency department visits annually for diplopia. Most ambulatory visits occurred with ophthalmologists (70.4%), and diplopia was frequently the primary reason for ambulatory setting (48.6%) or emergency department (36.5%) visits. []

International

International incidence rates of diplopia are unknown. The incidence of diplopia as a chief complaint in emergency departments is low. One study of a specialist eye hospital in London, United Kingdom, reported the incidence of diplopia as the chief complaint in only 1.4% of the presenting cases. []

Mortality/Morbidity

Divergent pathologic processes, each with its own morbidity and mortality, can cause diplopia. However, irrespective of cause, diplopia has significant morbidity in terms of difficulty with depth perception and confusion with orientation of objects, especially when performing visually demanding tasks, such as driving a vehicle or operating tools. Therefore, in assessing visual disability after injuries, loss of binocularity accounts for a major percentage of loss of function.

Race

Diplopia has no reported racial predilection.

Sex

Diplopia has no reported sexual predilection.

Age

Diplopia is encountered almost exclusively in adults or in those with mature visual systems because of their inability to ignore the second image.

Young children may not be able to express this symptom. More importantly, the immature visual system deals with diplopia by suppressing the poorer image, possibly resulting in irreversible amblyopia. Children with obvious and marked ocular malalignment due to strabismus are comfortable and content because the visual image from the deviating eye is suppressed and not noticed.

eMedicine Logo
Previous
Next:

Prognosis

The causes of diplopia can vary from a mild inconvenience to a condition with major health consequences. []

As a rule, patients with diabetic mononeuritis multiplex recover spontaneously in approximately 6 weeks.

Optical causes (eg, lens dislocation, corneal disorders) are amenable to repair.

Blow-out fractures have a variable prognosis depending on the amount of tissue damage.

Central (neurologic) causes of diplopia can have serious consequences and, in the case of primary or secondary tumors, have a dire prognosis.

eMedicine Logo
Previous
Next:

Patient Education

Patients must be educated on the importance of determining the exact cause of diplopia, since some conditions responsible for diplopia may be very serious. Otherwise, a clear explanation of the condition, its natural history, alternative options, and general prognosis will alleviate patient concerns and motivate perseverance. []

eMedicine Logo
Previous
References
  1. Najem K, Asuncion RMD, Margolin E. Diplopia. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. [Full Text].

  2. Rucker JC. Oculomotor disorders. Semin Neurol. 2007 Jul. 27(3):244-56. [QxMD MEDLINE Link].

  3. Stager DR Sr, Black T, Felius J. Unilateral lateral rectus resection for horizontal diplopia in adults with divergence insufficiency. Graefes Arch Clin Exp Ophthalmol. 2013 Mar 22. [QxMD MEDLINE Link].

  4. Migliorini R, Fratipietro M, Segnalini A, Arrico L. Persistent vertical diplopia after cataract surgery: a case report. Clin Ter. 2013. 164(1):e31-3. [QxMD MEDLINE Link].

  5. De Lott LB, Kerber KA, Lee PP, Brown DL, Burke JF. Diplopia-Related Ambulatory and Emergency Department Visits in the United States, 2003-2012. JAMA Ophthalmol. October 26, 2017. 135(12):1339–1344. [Full Text].

  6. Morris RJ. Double vision as a presenting symptom in an ophthalmic casualty department. Eye (Lond). 1991. 5 ( Pt 1):124-9. [QxMD MEDLINE Link].

  7. Holmes JM, Liebermann L, Hatt SR, Smith SJ, Leske DA. Quantifying Diplopia with a Questionnaire. Ophthalmology. 2013 Mar 23. [QxMD MEDLINE Link].

  8. Fraunfelder FW, Fraunfelder FT. Diplopia and fluoroquinolones. Ophthalmology. 2009 Sep. 116(9):1814-7. [QxMD MEDLINE Link].

  9. Merino PS, Vera RE, Mariñas LG, Gómez de Liaño PS, Escribano JV. Botulinum toxin for treatment of restrictive strabismus. J Optom. 2016 Oct 19. [QxMD MEDLINE Link].

  10. Alves M, Miranda A, Narciso MR, Mieiro L, Fonseca T. Diplopia: a diagnostic challenge with common and rare etiologies. Am J Case Rep. 2015 Apr 13. 16:220-3. [QxMD MEDLINE Link].

  11. Bender MD. Polyopia and monocular diplopia of cerebral origin. Arch Neurol Psychiatry. 1945. 54:323-38.

  12. Gersztenkorn D, Lee AG. Palinopsia revamped: a systematic review of the literature. Surv Ophthalmol. 2015 Jan-Feb. 60(1):1-35. [Full Text].

  13. Richards J, Howard JF Jr. Seronegative myasthenia gravis associated with malignant thymoma. Neuromuscul Disord. 2017 Feb 2. [QxMD MEDLINE Link].

  14. Shah HA, Shipchandler TZ, Sufyan AS, Nunery WR, Lee HB. Use of fracture size and soft tissue herniation on computed tomography to predict diplopia in isolated orbital floor fractures. Am J Otolaryngol. 2013 Mar 22. [QxMD MEDLINE Link].

  15. Murchison AP, Gilbert ME, Savino PJ. Neuroimaging and acute ocular motor mononeuropathies: a prospective study. Arch Ophthalmol. 2011 Mar. 129(3):301-5. [QxMD MEDLINE Link].

  16. Selvan VA. Single-fiber EMG: A review. Ann Indian Acad Neurol. 2011 Jan. 14 (1):64-7. [QxMD MEDLINE Link].

  17. Phillips PH. Treatment of diplopia. Semin Neurol. 2007 Jul. 27(3):288-98. [QxMD MEDLINE Link].

  18. Kaur K, Gurnani B. Fresnel Prisms. StatPearls. Treasure Island (FL): StatPearls Publishing [Internet]; 2024 Jan. [Full Text].

  19. Lavin PJM. Diplopia. Bradley's Neurology in Clinical Practice. Seventh Edition. Elsevier Inc; 2016. 528-72.

  20. Hatt SR, Leske DA, Holmes JM. Comparing methods of quantifying diplopia. Ophthalmology. 2007 Dec. 114(12):2316-22. [QxMD MEDLINE Link].

  21. Holmes JM, Leske DA, Kupersmith MJ. New methods for quantifying diplopia. Ophthalmology. 2005 Nov. 112(11):2035-9. [QxMD MEDLINE Link].

  22. Anderson MW, Sharma K, Feeney CM. Wound botulism associated with black tar heroin. Acad Emerg Med. 1997 Aug. 4(8):805-9. [QxMD MEDLINE Link].

  23. Astin CL. The use of occluding tinted contact lenses. CLAO J. 1998 Apr. 24(2):125-7. [QxMD MEDLINE Link].

  24. Batocchi AP, Evoli A, Majolini L, et al. Ocular palsies in the absence of other neurological or ocular symptoms: analysis of 105 cases. J Neurol. 1997 Oct. 244(10):639-45. [QxMD MEDLINE Link].

  25. Berman EL. Clues in the eye: ocular signs of metabolic and nutritional disorders. Geriatrics. 1995 Jul. 50(7):34-6, 43-4. [QxMD MEDLINE Link].

  26. Bielschowski A. Disturbance of vertical motor muscles of the eyes. Arch Ophthalmol. 1938. 20:175-200.

  27. Brazis PW, Lee AG. Binocular vertical diplopia. Mayo Clin Proc. 1998 Jan. 73(1):55-66. [QxMD MEDLINE Link].

  28. Campbell C. Corneal aberrations, monocular diplopia, and ghost images: analysis using corneal topographical data. Optom Vis Sci. 1998 Mar. 75(3):197-207. [QxMD MEDLINE Link].

  29. Capo H, Roth E, Johnson T, et al. Vertical strabismus after cataract surgery. Ophthalmology. 1996 Jun. 103(6):918-21. [QxMD MEDLINE Link].

  30. Dengis CA, Steinbach MJ, Ono H, et al. Learning to look with one eye: the use of head turn by normals and strabismics. Vision Res. 1996 Oct. 36(19):3237-42. [QxMD MEDLINE Link].

  31. Fingeret M. Forced duction test. Atlas of Primary Eyecare Procedures. Norwalk, Conn: Appleton & Lange; 1990. 138-44.

  32. Fowler MS, Wade DT, Richardson AJ, et al. Squints and diplopia seen after brain damage. J Neurol. 1996 Jan. 243(1):86-90. [QxMD MEDLINE Link].

  33. Galimberti CA, Versino M, Sartori I, et al. Epileptic skew deviation. Neurology. 1998 May. 50(5):1469-72. [QxMD MEDLINE Link].

  34. Gladstone GJ. Ophthalmologic aspects of thyroid-related orbitopathy. Endocrinol Metab Clin North Am. 1998 Mar. 27(1):91-100. [QxMD MEDLINE Link].

  35. Goldenberg AS. Transient diplopia as a result of block injections. Mandibular and posterior superior alveolar. N Y State Dent J. 1997 May. 63(5):29-31. [QxMD MEDLINE Link].

  36. Hahn JS, Berquist W, Alcorn DM, et al. Wernicke encephalopathy and beriberi during total parenteral nutrition attributable to multivitamin infusion shortage. Pediatrics. 1998 Jan. 101(1):E10. [QxMD MEDLINE Link].

  37. Hayreh SS, Podhajsky PA, Zimmerman B. Occult giant cell arteritis: ocular manifestations. Am J Ophthalmol. 1998 Apr. 125(4):521-6. [QxMD MEDLINE Link].

  38. Ing E, Kennerdell JS. The evaluation and treatment of extraocular motility deficits. Otolaryngol Clin North Am. 1997 Oct. 30(5):877-92. [QxMD MEDLINE Link].

  39. Kasner SE, Liu GT, Galetta SL. Neuro-ophthalmologic aspects of aneurysms. Neuroimaging Clin N Am. 1997 Nov. 7(4):679-92. [QxMD MEDLINE Link].

  40. Kolling GH. [Reflections on expert assessment of double vision and forced head position]. Klin Monatsbl Augenheilkd. 1996 Jan. 208(1):63-5. [QxMD MEDLINE Link].

  41. Kushner BJ, Kowal L. Diplopia after refractive surgery: occurrence and prevention. Arch Ophthalmol. 2003 Mar. 121(3):315-21. [QxMD MEDLINE Link].

  42. Kutschke PJ. Taking a history of the patient with diplopia. Insight. 1996 Sep. 21(3):92-5. [QxMD MEDLINE Link].

  43. Lasley DJ, Kivlin J, Rich L, et al. Stereo-discrimination between diplopic images in clinically normal observers. Invest Ophthalmol Vis Sci. 1984 Nov. 25(11):1316-20. [QxMD MEDLINE Link].

  44. Marzo ME, Perez Lopez-Fraile I, Capablo JL, et al. [Ocular myasthenia: clinical course and strategies for treatment]. Rev Neurol. 1998 Mar. 26(151):398-400. [QxMD MEDLINE Link].

  45. Miller NR. Lesions of the supranuclear ocular motor pathways. Walsh and Hoyt's Clinical Neuro-Ophthalmology. 4th ed. Baltimore, Md: Lippincott Williams & Wilkins; 1985. 707-715.

  46. Muneer A, Jones NS, Bradley PJ, et al. ENT pathology and diplopia. Eye. 1998. 12 (Pt 4):672-8. [QxMD MEDLINE Link].

  47. Ottar WL. Diplopia: double the fun! Part 1: History taking. Insight. 1998 Dec. 23(4):119-25. [QxMD MEDLINE Link].

  48. Richardson LD, Joyce DM. Diplopia in the emergency department. Emerg Med Clin North Am. 1997 Aug. 15(3):649-64. [QxMD MEDLINE Link].

  49. Safran AB, Vibert D, Häusler R. [Vestibular neuritis: a frequently unrecognized cause of diplopia]. Klin Monatsbl Augenheilkd. 1995 May. 206(5):413-5. [QxMD MEDLINE Link].

  50. Schachat AP. Diplopia. Diagnostic Diagrams: Ophthalmology. Baltimore: Lippincott Williams & Wilkins; 1984. 101-107.

  51. Seminari E, Cocchi L, Antoniazzi E, et al. [Clinical significance of diplopia in HIV infection. Assessment of a personal caseload and review of the literature]. Minerva Med. 1996 Nov. 87(11):515-23. [QxMD MEDLINE Link].

  52. Shumrick KA, Kersten RC, Kulwin DR, et al. Criteria for selective management of the orbital rim and floor in zygomatic complex and midface fractures. Arch Otolaryngol Head Neck Surg. 1997 Apr. 123(4):378-84. [QxMD MEDLINE Link].

  53. Stangler-Zuschrott E. [Disturbing physiologic diplopia (author's transl)]. Klin Monatsbl Augenheilkd. 1979 Mar. 174(3):370-3. [QxMD MEDLINE Link].

  54. Werner SC. Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab. 1977 Jan. 44(1):203-4. [QxMD MEDLINE Link].

  55. Woods RL, Bradley A, Atchison DA. Monocular diplopia caused by ocular aberrations and hyperopic defocus. Vision Res. 1996 Nov. 36(22):3597-606. [QxMD MEDLINE Link].

  56. Rucker JC, Phillips PH. Efferent Vision Therapy. J Neuroophthalmol. 2017 Jan 4. [QxMD MEDLINE Link].

  57. Joyce KE, Beyer F, Thomson RG, Clarke MP. A systematic review of the effectiveness of treatments in altering the natural history of intermittent exotropia. Br J Ophthalmol. 2015 Apr. 99 (4):440-50. [QxMD MEDLINE Link].

  58. Benatar M, Hammad M, Doss-Riney H. Concentric-needle single-fiber electromyography for the diagnosis of myasthenia gravis. Muscle Nerve. 2006 Aug. 34 (2):163-8. [QxMD MEDLINE Link].

  59. Dinkin M. Diagnostic approach to diplopia. Continuum (Minneap Minn). 2014 Aug. 20 (4 Neuro-ophthalmology):942-65. [QxMD MEDLINE Link].

Media Gallery
of 0
Tables
Table. Drugs Associated with Diplopia

Medication

Risk for diplopia

Lacosamide

Very common (≥1/10)

Zonisamide

Very common (≥1/10)

Eslicarbazepine

Common (≥1/100 to < 1/10)

Botulinum toxin

Common (≥1/100 to < 1/10)

Rufinamide

Common (≥1/100 to < 1/10)

Pregabalin

Common (≥1/100 to < 1/10)

Perampanel

Common (≥1/100 to < 1/10)

Temozolomide

Common (≥1/100 to < 1/10)

Zicotinamide

Common (≥1/100 to < 1/10)

Sildenafil

Common (≥1/100 to < 1/10)

Gabapentin

Common (≥1/100 to < 1/10)

Topiramate

Common (≥1/100 to < 1/10)

Zaleplon

Uncommon (≥1/1000 to < 1/100)

Levetiracetam

Uncommon (≥1/1000 to < 1/100)

Bortezomib

Uncommon (≥1/1000 to < 1/100)

Amlodipine

Uncommon (≥1/1000 to < 1/100)

Adalimumab

Uncommon (≥1/1000 to < 1/100)

Pravastatin

Uncommon (≥1/1000 to < 1/100)

Lamotrigine

Uncommon (≥1/1000 to < 1/100)

Capecitabine

Uncommon (≥1/1000 to < 1/100)

Telithromycin

Rare (≥1/10000 to < 1/1000)

Voriconazole

Rare (≥1/10000 to < 1/1000)

Dextromethorphan/Quinidine

Rare (≥1/10,000 to < 1/1000)

Sertraline

Rare (≥1/10,000 to < 1/1000)

Ciprofloxacin

Rare (≥1/10,000 to < 1/1000)

Table. Drugs Associated with Diplopia

Contributor Information and Disclosures
Author

Jitander Dudee, MD, MA(Cantab), FACS, FRCOphth Ophthalmologist, Medical Vision Institute, PSC

Jitander Dudee, MD, MA(Cantab), FACS, FRCOphth is a member of the following medical societies: American Academy of Ophthalmology, Kentucky Medical Association, Royal College of Ophthalmologists

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Chief Editor

Andrew G Lee, MD Chair, Department of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital; Clinical Professor, Associate Program Director, Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch School of Medicine; Clinical Professor, Department of Surgery, Division of Head and Neck Surgery, University of Texas MD Anderson Cancer Center; Professor of Ophthalmology, Neurology, and Neurological Surgery, Weill Medical College of Cornell University; Clinical Associate Professor, University of Buffalo, State University of New York School of Medicine

Andrew G Lee, MD is a member of the following medical societies: American Academy of Ophthalmology, American Geriatrics Society, Houston Neurological Society, Houston Ophthalmological Society, International Council of Ophthalmology, North American Neuro-Ophthalmology Society, Texas Ophthalmological Association

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: AstraZeneca; Bristol Myers Squibb; Horizon<br/>Serve(d) as a speaker or a member of a speakers bureau for: Horizon<br/>Received ownership interest from Credential Protection for other.

Additional Contributors

Andrew W Lawton, MD Neuro-Ophthalmology, Ochsner Health Services

Andrew W Lawton, MD is a member of the following medical societies: American Academy of Ophthalmology, Arkansas Medical Society, Southern Medical Association

Disclosure: Nothing to disclose.

Ama Sadaka, MD Resident Physician, Department of Ophthalmology, University of Cincinnati Hospital

Ama Sadaka, MD is a member of the following medical societies: Alpha Omega Alpha

Disclosure: Nothing to disclose.

Shauna Berry, DO Pediatric Ophthalmology and Neuro-ophthalmology

Shauna Berry, DO is a member of the following medical societies: American Academy of Ophthalmology, American Osteopathic Association, American Osteopathic Colleges of Ophthalmology and Otolaryngology-Head and Neck Surgery, Florida Osteopathic Medical Association, Women in Ophthalmology, Inc

Disclosure: Nothing to disclose.

Bayan Ali Mahmoud Al Othman, MD Fellow in Neuro-Ophthalmology, Houston Methodist Hospital

Disclosure: Nothing to disclose.

Acknowledgements

Izak F Wessels, MBBCh, MMed, FRCSE, FACS Adjunct Associate Professor, Loma Linda University; Private Practice in Comprehensive and Surgical Ophthalmology, Allied Eye Associates

Izak F Wessels, MBBCh, MMed, FRCSE, FACS is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, American Medical Association, and Royal College of Surgeons of England

Disclosure: Nothing to disclose.

Brian R Younge, MD Professor of Ophthalmology, Mayo Clinic School of Medicine

Brian R Younge, MD is a member of the following medical societies: American Medical Association, American Ophthalmological Society, and North American Neuro-Ophthalmology Society

Disclosure: Nothing to disclose.

What would you like to print?
What would you like to print?
Medscape Logo
Find Us On
All material on this website is protected by copyright, Copyright © 1994-2025 by WebMD LLC. This website also contains material copyrighted by 3rd parties.
[フレーム]

AltStyle によって変換されたページ (->オリジナル) /